-
European and US Drug Shortages: A Critical Analysis of Key Trends and Causes
Sep 9, 2025, 16:22 PM -
Landscape Analysis of Initiatives to Improve Access to Orphan Drugs Led by Industry Patient and Academic Stakeholders
Sep 9, 2025, 16:22 PM -
Healthcare Costs of Mammography Screening and Breast Cancer Treatment: A Registry-Based Study From Norway
Sep 9, 2025, 16:22 PM -
Mapping Writer-AI Conversations for HTA: Preliminary Analysis of 7009 Messages
Sep 9, 2025, 16:22 PM -
Utilization of Best-Value Medicines for Teriparatide in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM -
Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of First-Line Therapies for Microsatellite-Instability-High (MSI-H) or Mismatch-Repair-Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (mCRC) in France
Sep 9, 2025, 16:22 PM -
Cost-Minimization Analysis and Economic Impact in EGPA: Evidence From MANDARA
Sep 9, 2025, 16:22 PM -
Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada
Sep 9, 2025, 16:22 PM -
Evaluating Bayesian Borrowing Methods for Treatment Effect Extrapolation: A Simulation-Based Study
Sep 9, 2025, 16:22 PM -
Mental Health Benefits of Exercise Variation: Evidence From the 2024 5EU National Health and Wellness Survey
Sep 9, 2025, 16:22 PM -
Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States
Sep 9, 2025, 16:22 PM -
The Incidence and Economic Impact of Major Adverse Events Associated With Intravascular Temperature Management: A Systematic Review, Analysis, and Model
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness as Part of the German AMNOG Process Analyzing the 2025 SVR Proposal and Its Implementation Challenges
Sep 9, 2025, 16:22 PM -
Understanding the Needs and Aspirations of Emerging HEOR Talent: Results From the ISPOR New Professional and Student Survey
Sep 9, 2025, 16:22 PM -
Diagnostic Odyssey of Patients With the Rare Immunodeficiency-Activated PI3 Kinase Delta Syndrome (APDS): Case Study With Expert Interviews and Patient Surveys
Sep 9, 2025, 16:22 PM -
Quality and Impact of Real-World Data in Chronic Disease Research: Insights From Retrospective Studies Using the Hospital Episode Statistics (HES) Database
Sep 9, 2025, 16:22 PM -
Ischemic Stroke in Europe: Incidence Trends Over Three Decades (1991-2021)
Sep 9, 2025, 16:22 PM -
From Complex Statistics to Clinically Meaningful Insights: Interpreting Results in Meta-Analyses of Continuous Outcomes
Sep 9, 2025, 16:22 PM -
Site of Care Cost-Effectiveness of Axicabtagene Ciloleucel in Relapsed/Refractory Second-Line or Later Large B-cell Lymphoma in the United States: Analyses for Inpatient and Outpatient Infusion Settings
Sep 9, 2025, 16:22 PM
